Antimicrobial treatment of Helicobacter pylori infection

Clinical Infectious Diseases

Volumn 25, Issue 5, 1997, Pages 1023-1026

  Stewart Goodwin, C ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; BISMUTH CITRATE; BISMUTH DERIVATIVE; BISMUTH SALICYLATE; CARBAMAZEPINE; CLARITHROMYCIN; DIGOXIN; ERYTHROMYCIN; FURAZOLIDONE; HISTAMINE H2 RECEPTOR ANTAGONIST; MACROLIDE; METRONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; OFLOXACIN; OMEPRAZOLE; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RANITIDINE BISMUTH CITRATE; SUCRALFATE; TETRACYCLINE; TINIDAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CONFERENCE PAPER; DRUG INDUCED DISEASE; GASTRITIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HEADACHE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TASTE DISORDER; TREATMENT FAILURE;

EID: 20644465199     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516078     Document Type: Conference Paper

References (23)

1. Cederbrant G, Kahlmeter G, Ljungh A. The E test for antimicrobial susceptibility testing of Helicobacter pylori. J Antimicrob Chemother 1993;31:65-71.
2. Goodwin CS, Marshall BJ, Blincow ED, Wilson DH, Blackbourn S, Phillips M. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. J Clin Pathol 1988;41:207-10.
3. Megraud F. Rationale for the choice of antibiotics for the eradication of Helicobacter pylori. Euro J Gastroenterol Hepatol 1995;7(suppl 1): S49-54.
4. Graham DY. Clarithromycin for treatment of Helicobacter pylori infections. Euro J Gastroenterol Hepatol 1995;7(suppl 1):S55-8.
5. McNulty CAM, Dent JC, Ford FGA, Wilkinson SP. Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa. J Antimicrob Chemother 1988;22:729-38.
6. Hunt RH. The role of acid suppression in the treatment of H. pylori infection. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori-basic mechanisms to clinical cure. Dordrecht: Kluwer, 1994:584-92.
7. Götz JM, Veenendaal RA, Veselic M, Bernards S, Lamers CBHW. Triple therapy with ranitidine, clarithromycin, and metronidazole in the treatment of Helicobacter pylori. Scand J Gastroenterol 1995;30(suppl 212): 34-7.
8. Borody TJ, Cole O, Norman S, et al. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Aust 1989;151:431-5.
9. Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990;335:1233-5.
10. Borody TJ, Andrews P, Fracchia G, Brandi S, Shortis NP, Bae H. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995;37:477-81.
11. Mégraud F, Cayla R, Lamouliatte H, Bouchard S, Darmaillac V. Surveillance of Helicobacter pylori resistance to macrolides and nitroimidazole compounds at a national level [abstract]. Am J Gastroenterol 1994;89:1368.
12. Moayydei P, Axon ATR. Helicobacter pylori research explosion. Eur J Gastroenterol Hepatol 1995;7:835-40.
13. Glupczynski Y, Burette A. Failure of azythromycin to eradicate Campylobacter pylori from the stomach because of acquired resistance during treatment. Am J Gastroenterol 1990;85:98-9.
14. Glupczynski Y, Labbe M, Burette A, Delmee M, Avesani V, Bruck C. Treatment failure of ofloxacin in Campylobacter pylori infection. Lancet 1987;1:1096.
15. Hirschl AM, Hentschel E, Schütze K, et al. The efficacy of antimicrobial treatment in Campylobacter pylori-associated gastritis and duodenal ulcer. Scand J Gastroenterol 1988;23(suppl 142):76-81.
16. Bardhan KD, Dellaire C, Eisold H, Duggan AE. GR122311X (ranitidine bismuth citrate) with clarithromycin for the treatment of duodenal ulcer. Gastroenterol 1995;108(suppl):A53.
17. O'Morain C, Schulz TB, Tam C-Y, Dixon MF, Quirke P, Duggan AE. GR122311X (ranitidine bismuth citrate) with amoxycillin for the eradication of Helicobacter pylori. Gut 1995;37(suppl 1):A42.
18. Lam SK, Hu WHC, Ching CK. Sucralfate in Helicobacter pylori eradication strategies. Scand J Gastroenterol 1995;30:89-92.
19. Resende LM, Queiroz DM, Barbosa AJ, et al. Histology of the mucosa of gastric antrum and body before and after eradication of Helicobacter pylori. Brazil J Med Biol Res 1993;26:1279-89.
20. Reilly TG, Ayres RCS, Poxon V, Walt RP. Helicobacter pylori eradication in a clinical setting: success rates and the effect on the quality of life in peptic ulcer. Ali Pharm Ther 1995;9:483-90.
21. Goodwin CS, McNulty CAM. Bacteriological and pharmacological basis for the treament of Helicobacter pylori infection. In: Rathbone D, Heatley V, eds. Helicobacter pylori and gastroduodenal disease. 2nd ed. Oxford: Blackwell, 1992:224-31.
22. Metz DC, Getz HD. Helicobacter pylori gastritis therapy with omeprazole and clarithromycin increases serum carbamazepine levels. Dig Dis Sci 1995;40:912-5.
23. Ford A, Smith LC, Baltch AL, Smith RP. Clarithromycin-induced digoxin toxicity in a patient with AIDS. Clin Infect Dis 1995;21:1051-2.